Moderna shares double on melanoma vaccine trial success

Published: 2026-08-19

Moderna shares double on melanoma vaccine trial success
Drugmaker’s cancer shot developed with Merck delivers positive outcome in late-stage trial

Originally sourced from Financial Times (Tech/Business)

Read the full story on Global Insight Daily